Defining the clinicoradiologic syndrome of SARS-CoV-2 acute necrotizing encephalopathy

BACKGROUND AND OBJECTIVES: We characterize clinical and neuroimaging features of SARS-CoV-2-related acute necrotizing encephalopathy (ANE). METHODS: Systematic review of English language publications in PubMed and reference lists between January 1, 2020, and June 30, 2023, in accordance with PRISMA...

Full description

Bibliographic Details
Main Authors: Lee, Vanessa W., Kam, Kai Qian, Mohamed, Ahmad R., Musa, Husna, Anandakrishnan, Poorani, Shen, Qingtang, Palazzo, Alexander F., Dale, Russell C., Lim, Ming, Thomas, Terrence
Format: Article
Language:English
Published: Lippincott Williams & Wilkins 2024
Online Access:http://psasir.upm.edu.my/id/eprint/105828/1/NXI.0000000000200186.pdf
_version_ 1811137699741958144
author Lee, Vanessa W.
Kam, Kai Qian
Mohamed, Ahmad R.
Musa, Husna
Anandakrishnan, Poorani
Shen, Qingtang
Palazzo, Alexander F.
Dale, Russell C.
Lim, Ming
Thomas, Terrence
author_facet Lee, Vanessa W.
Kam, Kai Qian
Mohamed, Ahmad R.
Musa, Husna
Anandakrishnan, Poorani
Shen, Qingtang
Palazzo, Alexander F.
Dale, Russell C.
Lim, Ming
Thomas, Terrence
author_sort Lee, Vanessa W.
collection UPM
description BACKGROUND AND OBJECTIVES: We characterize clinical and neuroimaging features of SARS-CoV-2-related acute necrotizing encephalopathy (ANE). METHODS: Systematic review of English language publications in PubMed and reference lists between January 1, 2020, and June 30, 2023, in accordance with PRISMA guidelines. Patients with SARS-CoV-2 infection who fulfilled diagnostic criteria for sporadic and genetic ANE were included. RESULTS: From 899 articles, 20 cases (17 single case reports and 3 additional cases) were curated for review (50 female; 8 were children). Associated COVID-19 illnesses were febrile upper respiratory tract infections in children while adults had pneumonia (45.6) and myocarditis (8.2). Children had early neurologic deterioration (median day 2 in children vs day 4 in adults), seizures (5 (62.5) children vs 3 of 9 (33.3) adults), and motor abnormalities (6 of 7 (85.7) children vs 3 of 7 (42.9) adults). Eight of 12 (66.7) adults and 4 (50.0) children had high-risk ANE scores. Five (62.5) children and 12 (66.7) adults had brain lesions bilaterally and symmetrically in the putamina, external capsules, insula cortex, or medial temporal lobes, in addition to typical thalamic lesions of ANE. Hypotension was only seen in adults (30). Hematologic derangements were common: lymphopenia (66.7), coagulopathy (60.0), or elevated D-dimers (100), C-reactive protein (91.7), and ferritin (62.5). A pathogenic heterozygous c/.1754 C>T variant in RANBP2 was present in 2 children: one known to have this before SARS-CoV-2 infection, and a patient tested because the SARS-CoV-2 infection was the second encephalopathic illness. Three other children with no prior encephalopathy or family history of encephalopathy were negative for this variant. Fifteen (75) received immunotherapy (with IV methylprednisolone, immunoglobulins, tocilizumab, or plasma exchange): 6 (40.0) with monotherapy and 9 (60.0) had combination therapy. Deaths were in 8 of 17 with data (47.1): a 2-month-old male infant and 7 adults (87.5) of median age 56 years (33-70 years), 4 of whom did not receive immunotherapy. DISCUSSION: Children and adults with SARS-CoV-2 ANE have similar clinical features and neuroimaging characteristics. Mortality is high, predominantly in patients not receiving immunotherapy and at the extremes of age.
first_indexed 2024-09-25T03:38:27Z
format Article
id upm.eprints-105828
institution Universiti Putra Malaysia
language English
last_indexed 2024-09-25T03:38:27Z
publishDate 2024
publisher Lippincott Williams & Wilkins
record_format dspace
spelling upm.eprints-1058282024-07-15T04:00:32Z http://psasir.upm.edu.my/id/eprint/105828/ Defining the clinicoradiologic syndrome of SARS-CoV-2 acute necrotizing encephalopathy Lee, Vanessa W. Kam, Kai Qian Mohamed, Ahmad R. Musa, Husna Anandakrishnan, Poorani Shen, Qingtang Palazzo, Alexander F. Dale, Russell C. Lim, Ming Thomas, Terrence BACKGROUND AND OBJECTIVES: We characterize clinical and neuroimaging features of SARS-CoV-2-related acute necrotizing encephalopathy (ANE). METHODS: Systematic review of English language publications in PubMed and reference lists between January 1, 2020, and June 30, 2023, in accordance with PRISMA guidelines. Patients with SARS-CoV-2 infection who fulfilled diagnostic criteria for sporadic and genetic ANE were included. RESULTS: From 899 articles, 20 cases (17 single case reports and 3 additional cases) were curated for review (50 female; 8 were children). Associated COVID-19 illnesses were febrile upper respiratory tract infections in children while adults had pneumonia (45.6) and myocarditis (8.2). Children had early neurologic deterioration (median day 2 in children vs day 4 in adults), seizures (5 (62.5) children vs 3 of 9 (33.3) adults), and motor abnormalities (6 of 7 (85.7) children vs 3 of 7 (42.9) adults). Eight of 12 (66.7) adults and 4 (50.0) children had high-risk ANE scores. Five (62.5) children and 12 (66.7) adults had brain lesions bilaterally and symmetrically in the putamina, external capsules, insula cortex, or medial temporal lobes, in addition to typical thalamic lesions of ANE. Hypotension was only seen in adults (30). Hematologic derangements were common: lymphopenia (66.7), coagulopathy (60.0), or elevated D-dimers (100), C-reactive protein (91.7), and ferritin (62.5). A pathogenic heterozygous c/.1754 C>T variant in RANBP2 was present in 2 children: one known to have this before SARS-CoV-2 infection, and a patient tested because the SARS-CoV-2 infection was the second encephalopathic illness. Three other children with no prior encephalopathy or family history of encephalopathy were negative for this variant. Fifteen (75) received immunotherapy (with IV methylprednisolone, immunoglobulins, tocilizumab, or plasma exchange): 6 (40.0) with monotherapy and 9 (60.0) had combination therapy. Deaths were in 8 of 17 with data (47.1): a 2-month-old male infant and 7 adults (87.5) of median age 56 years (33-70 years), 4 of whom did not receive immunotherapy. DISCUSSION: Children and adults with SARS-CoV-2 ANE have similar clinical features and neuroimaging characteristics. Mortality is high, predominantly in patients not receiving immunotherapy and at the extremes of age. Lippincott Williams & Wilkins 2024-01 Article PeerReviewed text en http://psasir.upm.edu.my/id/eprint/105828/1/NXI.0000000000200186.pdf Lee, Vanessa W. and Kam, Kai Qian and Mohamed, Ahmad R. and Musa, Husna and Anandakrishnan, Poorani and Shen, Qingtang and Palazzo, Alexander F. and Dale, Russell C. and Lim, Ming and Thomas, Terrence (2024) Defining the clinicoradiologic syndrome of SARS-CoV-2 acute necrotizing encephalopathy. Neurology(R) neuroimmunology & neuroinflammation, 11 (1). pp. 1-11. ISSN 2332-7812 https://www.neurology.org/doi/10.1212/NXI.0000000000200186 10.1212/NXI.0000000000200186
spellingShingle Lee, Vanessa W.
Kam, Kai Qian
Mohamed, Ahmad R.
Musa, Husna
Anandakrishnan, Poorani
Shen, Qingtang
Palazzo, Alexander F.
Dale, Russell C.
Lim, Ming
Thomas, Terrence
Defining the clinicoradiologic syndrome of SARS-CoV-2 acute necrotizing encephalopathy
title Defining the clinicoradiologic syndrome of SARS-CoV-2 acute necrotizing encephalopathy
title_full Defining the clinicoradiologic syndrome of SARS-CoV-2 acute necrotizing encephalopathy
title_fullStr Defining the clinicoradiologic syndrome of SARS-CoV-2 acute necrotizing encephalopathy
title_full_unstemmed Defining the clinicoradiologic syndrome of SARS-CoV-2 acute necrotizing encephalopathy
title_short Defining the clinicoradiologic syndrome of SARS-CoV-2 acute necrotizing encephalopathy
title_sort defining the clinicoradiologic syndrome of sars cov 2 acute necrotizing encephalopathy
url http://psasir.upm.edu.my/id/eprint/105828/1/NXI.0000000000200186.pdf
work_keys_str_mv AT leevanessaw definingtheclinicoradiologicsyndromeofsarscov2acutenecrotizingencephalopathy
AT kamkaiqian definingtheclinicoradiologicsyndromeofsarscov2acutenecrotizingencephalopathy
AT mohamedahmadr definingtheclinicoradiologicsyndromeofsarscov2acutenecrotizingencephalopathy
AT musahusna definingtheclinicoradiologicsyndromeofsarscov2acutenecrotizingencephalopathy
AT anandakrishnanpoorani definingtheclinicoradiologicsyndromeofsarscov2acutenecrotizingencephalopathy
AT shenqingtang definingtheclinicoradiologicsyndromeofsarscov2acutenecrotizingencephalopathy
AT palazzoalexanderf definingtheclinicoradiologicsyndromeofsarscov2acutenecrotizingencephalopathy
AT dalerussellc definingtheclinicoradiologicsyndromeofsarscov2acutenecrotizingencephalopathy
AT limming definingtheclinicoradiologicsyndromeofsarscov2acutenecrotizingencephalopathy
AT thomasterrence definingtheclinicoradiologicsyndromeofsarscov2acutenecrotizingencephalopathy